United States Afatinib Market Report 2018

Publisher Name :
Date: 16-Jul-2018
No. of pages: 95
Inquire Before Buying

In this report, the United States Afatinib market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

- The West

- Southwest

- The Middle Atlantic

- New England

- The South

- The Midwest

with sales (volume), revenue (value), market share and growth rate of Afatinib in these regions, from 2013 to 2025 (forecast).

United States Afatinib market competition by top manufacturers/players, with Afatinib sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

- Boehringer Ingelheim

- Teva Pharmaceutical Industries

- Myosynth

- Reva Pharma

- Tianjin Scipharmacn

- Hubei Purple Sakura Chemical

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- =98%

- <98%

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

- Non-Small Cell Lung Cancer

- Application 2

United States Afatinib Market Report 2018

Table of Contents
United States Afatinib Market Report 2018
1 Afatinib Overview
1.1 Product Overview and Scope of Afatinib
1.2 Classification of Afatinib by Product Category
1.2.1 United States Afatinib Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Afatinib Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 =98%
1.2.4 <98%
1.3 United States Afatinib Market by Application/End Users
1.3.1 United States Afatinib Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Non-Small Cell Lung Cancer
1.3.2 Application 2
1.4 United States Afatinib Market by Region
1.4.1 United States Afatinib Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Afatinib Status and Prospect (2013-2025)
1.4.3 Southwest Afatinib Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Afatinib Status and Prospect (2013-2025)
1.4.5 New England Afatinib Status and Prospect (2013-2025)
1.4.6 The South Afatinib Status and Prospect (2013-2025)
1.4.7 The Midwest Afatinib Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Afatinib (2013-2025)
1.5.1 United States Afatinib Sales and Growth Rate (2013-2025)
1.5.2 United States Afatinib Revenue and Growth Rate (2013-2025)
2 United States Afatinib Market Competition by Players/Suppliers
2.1 United States Afatinib Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Afatinib Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Afatinib Average Price by Players/Suppliers (2013-2018)
2.4 United States Afatinib Market Competitive Situation and Trends
2.4.1 United States Afatinib Market Concentration Rate
2.4.2 United States Afatinib Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Afatinib Manufacturing Base Distribution, Sales Area, Product Type
3 United States Afatinib Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Afatinib Sales and Market Share by Region (2013-2018)
3.2 United States Afatinib Revenue and Market Share by Region (2013-2018)
3.3 United States Afatinib Price by Region (2013-2018)
4 United States Afatinib Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Afatinib Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Afatinib Revenue and Market Share by Type (2013-2018)
4.3 United States Afatinib Price by Type (2013-2018)
4.4 United States Afatinib Sales Growth Rate by Type (2013-2018)
5 United States Afatinib Sales (Volume) by Application (2013-2018)
5.1 United States Afatinib Sales and Market Share by Application (2013-2018)
5.2 United States Afatinib Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities
6 United States Afatinib Players/Suppliers Profiles and Sales Data
6.1 Boehringer Ingelheim
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Afatinib Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Boehringer Ingelheim Afatinib Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Teva Pharmaceutical Industries
6.2.2 Afatinib Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Teva Pharmaceutical Industries Afatinib Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Myosynth
6.3.2 Afatinib Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Myosynth Afatinib Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Reva Pharma
6.4.2 Afatinib Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Reva Pharma Afatinib Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Tianjin Scipharmacn
6.5.2 Afatinib Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Tianjin Scipharmacn Afatinib Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Hubei Purple Sakura Chemical
6.6.2 Afatinib Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Hubei Purple Sakura Chemical Afatinib Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
7 Afatinib Manufacturing Cost Analysis
7.1 Afatinib Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Afatinib
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Afatinib Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Afatinib Major Manufacturers in 2017
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Afatinib Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States Afatinib Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Afatinib Sales Volume Forecast by Type (2018-2025)
11.3 United States Afatinib Sales Volume Forecast by Application (2018-2025)
11.4 United States Afatinib Sales Volume Forecast by Region (2018-2025)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Afatinib
Figure United States Afatinib Market Size (K Units) by Type (2013-2025)
Figure United States Afatinib Sales Volume Market Share by Type (Product Category) in 2017
Figure =98% Product Picture
Figure <98% Product Picture
Figure United States Afatinib Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Afatinib by Application in 2017
Figure Non-Small Cell Lung Cancer Examples
Table Key Downstream Customer in Non-Small Cell Lung Cancer
Table Key Downstream Customer in Application 2
Figure United States Afatinib Market Size (Million USD) by Region (2013-2025)
Figure The West Afatinib Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Afatinib Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Afatinib Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Afatinib Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Afatinib Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Afatinib Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Afatinib Sales (K Units) and Growth Rate (2013-2025)
Figure United States Afatinib Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Afatinib Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Afatinib Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Afatinib Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Afatinib Sales Share by Players/Suppliers
Figure 2017 United States Afatinib Sales Share by Players/Suppliers
Figure United States Afatinib Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Afatinib Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Afatinib Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Afatinib Revenue Share by Players/Suppliers
Figure 2017 United States Afatinib Revenue Share by Players/Suppliers
Table United States Market Afatinib Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Afatinib Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Afatinib Market Share of Top 3 Players/Suppliers
Figure United States Afatinib Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Afatinib Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Afatinib Product Category
Table United States Afatinib Sales (K Units) by Region (2013-2018)
Table United States Afatinib Sales Share by Region (2013-2018)
Figure United States Afatinib Sales Share by Region (2013-2018)
Figure United States Afatinib Sales Market Share by Region in 2017
Table United States Afatinib Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Afatinib Revenue Share by Region (2013-2018)
Figure United States Afatinib Revenue Market Share by Region (2013-2018)
Figure United States Afatinib Revenue Market Share by Region in 2017
Table United States Afatinib Price (USD/Unit) by Region (2013-2018)
Table United States Afatinib Sales (K Units) by Type (2013-2018)
Table United States Afatinib Sales Share by Type (2013-2018)
Figure United States Afatinib Sales Share by Type (2013-2018)
Figure United States Afatinib Sales Market Share by Type in 2017
Table United States Afatinib Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Afatinib Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Afatinib by Type (2013-2018)
Figure Revenue Market Share of Afatinib by Type in 2017
Table United States Afatinib Price (USD/Unit) by Types (2013-2018)
Figure United States Afatinib Sales Growth Rate by Type (2013-2018)
Table United States Afatinib Sales (K Units) by Application (2013-2018)
Table United States Afatinib Sales Market Share by Application (2013-2018)
Figure United States Afatinib Sales Market Share by Application (2013-2018)
Figure United States Afatinib Sales Market Share by Application in 2017
Table United States Afatinib Sales Growth Rate by Application (2013-2018)
Figure United States Afatinib Sales Growth Rate by Application (2013-2018)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Afatinib Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim Afatinib Sales Growth Rate (2013-2018)
Figure Boehringer Ingelheim Afatinib Sales Market Share in United States (2013-2018)
Figure Boehringer Ingelheim Afatinib Revenue Market Share in United States (2013-2018)
Table Teva Pharmaceutical Industries Basic Information List
Table Teva Pharmaceutical Industries Afatinib Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Teva Pharmaceutical Industries Afatinib Sales Growth Rate (2013-2018)
Figure Teva Pharmaceutical Industries Afatinib Sales Market Share in United States (2013-2018)
Figure Teva Pharmaceutical Industries Afatinib Revenue Market Share in United States (2013-2018)
Table Myosynth Basic Information List
Table Myosynth Afatinib Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Myosynth Afatinib Sales Growth Rate (2013-2018)
Figure Myosynth Afatinib Sales Market Share in United States (2013-2018)
Figure Myosynth Afatinib Revenue Market Share in United States (2013-2018)
Table Reva Pharma Basic Information List
Table Reva Pharma Afatinib Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Reva Pharma Afatinib Sales Growth Rate (2013-2018)
Figure Reva Pharma Afatinib Sales Market Share in United States (2013-2018)
Figure Reva Pharma Afatinib Revenue Market Share in United States (2013-2018)
Table Tianjin Scipharmacn Basic Information List
Table Tianjin Scipharmacn Afatinib Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Tianjin Scipharmacn Afatinib Sales Growth Rate (2013-2018)
Figure Tianjin Scipharmacn Afatinib Sales Market Share in United States (2013-2018)
Figure Tianjin Scipharmacn Afatinib Revenue Market Share in United States (2013-2018)
Table Hubei Purple Sakura Chemical Basic Information List
Table Hubei Purple Sakura Chemical Afatinib Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Hubei Purple Sakura Chemical Afatinib Sales Growth Rate (2013-2018)
Figure Hubei Purple Sakura Chemical Afatinib Sales Market Share in United States (2013-2018)
Figure Hubei Purple Sakura Chemical Afatinib Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Afatinib
Figure Manufacturing Process Analysis of Afatinib
Figure Afatinib Industrial Chain Analysis
Table Raw Materials Sources of Afatinib Major Players/Suppliers in 2017
Table Major Buyers of Afatinib
Table Distributors/Traders List
Figure United States Afatinib Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Afatinib Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Afatinib Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Afatinib Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Afatinib Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Afatinib Sales Volume (K Units) Forecast by Type in 2025
Table United States Afatinib Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Afatinib Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Afatinib Sales Volume (K Units) Forecast by Application in 2025
Table United States Afatinib Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Afatinib Sales Volume Share Forecast by Region (2018-2025)
Figure United States Afatinib Sales Volume Share Forecast by Region (2018-2025)
Figure United States Afatinib Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Calcium Citrate Market 2018, Forecast to 2023
    Published: 14-Aug-2018        Price: US 4880 Onwards        Pages: 129
    Calcium Citrate provides 21% of elemental calcium and better absorbed than calcium carbonate in patients with higher gastric pH. Calcium citrate is the calcium salt of citric acid. It is prepared by neutralizing citric acid with calcium ydroxide or calcium carbonate and subsequent crystallization. It is most commonly found in the tetrahydrate form. Scope of the Report: This report focuses on the Calcium Citrate in global market, especially in North America, Europe and Asia-......
  • Global Calcium Citrate Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 14-Aug-2018        Price: US 3480 Onwards        Pages: 130
    Calcium Citrate provides 21% of elemental calcium and better absorbed than calcium carbonate in patients with higher gastric pH. Calcium citrate is the calcium salt of citric acid. It is prepared by neutralizing citric acid with calcium ydroxide or calcium carbonate and subsequent crystallization. It is most commonly found in the tetrahydrate form. Scope of the Report: This report focuses on the Calcium Citrate in global market, especially in North America, Europe and Asia-......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Fused Magnesia Market 2018, Forecast to 2023
    Published: 14-Aug-2018        Price: US 4880 Onwards        Pages: 133
    This report studies the Fused Magnesia market, Fused magnesia (FM) is produced by smelting of calcined magnesia in electric arc furnaces at above 3000°C. Fused magnesia is considered to be one of the best thermal and electrical insulators with high density, high purity and large crystals. Scope of the Report: This report focuses on the Fused Magnesia in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ca......
  • Global Fused Magnesia Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 14-Aug-2018        Price: US 3480 Onwards        Pages: 134
    This report studies the Fused Magnesia market, Fused magnesia (FM) is produced by smelting of calcined magnesia in electric arc furnaces at above 3000°C. Fused magnesia is considered to be one of the best thermal and electrical insulators with high density, high purity and large crystals. Scope of the Report: This report focuses on the Fused Magnesia in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ca......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) High Purity Iron Market 2018, Forecast to 2023
    Published: 14-Aug-2018        Price: US 4880 Onwards        Pages: 130
    High Purity Iron is refers to metal content of iron more than 99.9% (99.95%, 99.99%, etc.). Valuable characteristics can be attained by raising the purity of iron. Products made using high-purity iron offer a wide range of advantages, including resistance to impacts, heat and corrosion, as well as magnetic characteristics. Scope of the Report: This report focuses on the High Purity Iron in global market, especially in North America, Europe and Asia-P......
  • Global High Purity Iron Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 14-Aug-2018        Price: US 3480 Onwards        Pages: 136
    High Purity Iron is refers to metal content of iron more than 99.9% (99.95%, 99.99%, etc.). Valuable characteristics can be attained by raising the purity of iron. Products made using high-purity iron offer a wide range of advantages, including resistance to impacts, heat and corrosion, as well as magnetic characteristics. Scope of the Report: This report focuses on the High Purity Iron in global market, especially in North America, Europe and Asia-P......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Hydrogen Sulfide Removal Market 2018, Forecast to 2023
    Published: 14-Aug-2018        Price: US 4880 Onwards        Pages: 152
    Hydrogen sulfide (H2S) is a very toxic and pungent gas that causes problems in both the upstream and downstream oil Industry and gas industry. Hydrogen sulfide scavengers can remove the H2S from the upstream and downstream oil Industry and gas to reduce corrosion. Scope of the Report: This report focuses on the Hydrogen Sulfide Removal in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the m......
  • Global Hydrogen Sulfide Removal Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 14-Aug-2018        Price: US 3480 Onwards        Pages: 150
    Hydrogen sulfide (H2S) is a very toxic and pungent gas that causes problems in both the upstream and downstream oil Industry and gas industry. Hydrogen sulfide scavengers can remove the H2S from the upstream and downstream oil Industry and gas to reduce corrosion. Scope of the Report: This report focuses on the Hydrogen Sulfide Removal in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the m......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Drag Reducing Agent Market 2018, Forecast to 2023
    Published: 14-Aug-2018        Price: US 4880 Onwards        Pages: 136
    Drag reducing agent (DRA), also called drag reducer or flow improver, is a long chain polymer chemical that is used in crude oil, refined products or non-potable water pipelines. It is injected in small amounts (parts per million) and is used to reduce the frictional pressure drop along the pipeline's length. Its use has allowed pipeline systems to greatly increase in traditional capacity and extend the life of existing systems. Scope of the Report: This report focuses on t......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs